AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial. (nejm.org)

Authors: Lewis CJ … Tifft CJ Journal: New England Journal of Medicine Published: 2026-03-26 DOI: https://doi.org/10.1056/NEJMoa2510935